BRANDY WELLMON: Open Payments
NPI 1710903778 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$270 in 14 payments from 8 companies in 2025. Trend: 2023 $446 · 2024 $257 · 2025 $270
Food & beverage: $270
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 3 | $71 |
| Amgen Inc. | 3 | $54 |
| Dexcom, Inc. | 2 | $35 |
| Lilly USA, LLC | 2 | $33 |
| Sequel Med Tech, LLC | 1 | $22 |
| Medtronic, Inc. | 1 | $21 |
| ABBVIE INC. | 1 | $18 |
| SANOFI-AVENTIS U.S. LLC | 1 | $15 |
Products named: FREESTYLE LIBRE 3, Dexcom G6 Transmitter, MOUNJARO, EVENITY, TEPEZZA, TWIIST, MINIMED 780G, TZIELD.
Industry payments across TX — which companies pay providers there.
